This six-part program provides an overview of key concepts and skills for clinicians facing common challenges in the management of patients with chronic pain, including reducing the risks of opioids and addressing opioid use disorder.
The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario.
Provided by the Centre for Addiction and Mental Health (CAMH) and the College of Physicians and Surgeons of Ontario (CPSO)
Hello! Welcome to our new web site. This site is not fully supported in Internet Explorer 7 (and earlier) versions.
Please upgrade your Internet Explorer browser to a newer version.
As an alternative, you can use either of the options below to browse the site: